The Green Organic Dutchman Holdings Ltd.’s (“TGOD”) (TSX:TGOD) has closed its bought deal financing of 3.91 million special warrants of the company at $6.40 per special warrant for aggregate gross proceeds of approximately $25-million, previously announced on June 5, 2018. The offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp., acting as co-lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including PI Financial Corp. as co-lead underwriter, and Mackie Research Capital Corp. Each special warrant entitles the holder thereof to receive, upon voluntary exercise prior to or deemed exercise on the automatic exercise date and without payment of additional consideration, one unit of the company, subject to a penalty clause. The automatic exercise date is the earlier of: (i) Oct. 27, 2018, and (ii) the third business day after the date on which a receipt for a final short-form prospectus qualifying the units underlying the special warrants is issued by the Ontario Securities Commission.
Each unit consists of one common share of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase one common share at an exercise price of $9.50 for a period of 36 months from the date hereof.
In consideration for their services, the underwriters received cash commission of $1,501,440 and an aggregate of 234,600 underwriters’ special warrants. Each underwriters’ special warrant will be automatically exercised without payment of additional consideration into one underwriters’ common share purchase warrant on the automatic exercise date. Each underwriters’ warrant is exercisable into one common share at an exercise price of $6.40 per underwriters’ warrant share for a period of 36 months from the date hereof.
The company intends to use the net proceeds of the offering to finance strategic investments and international expansion opportunities.
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings is a research and development company licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
We seek Safe Harbor.